What's happening
This bill allows pharmacists to substitute prescribed brand name epinephrine auto-injectors with lower-cost alternatives, given patient consent and proper counseling.
Why it matters
Could lower out-of-pocket costs for patients. By explicitly allowing pharmacists to offer lower-cost alternatives (not just those on the official interchangeables list), this bill could make epinephrine auto-injectors more affordable for people who need them, potentially reducing financial barriers to access.
Expands patient choice beyond current substitution rules. The bill permits pharmacists to substitute even if the alternative device is not on the state's official list of interchangeable products, increasing the range of available options for patients.
Protects patient safety and autonomy through safeguards. Substitution is only allowed if the prescriber hasn't indicated "dispense as written," the patient is properly counseled on the use of the new device, and explicit consent is obtained, helping ensure patients are informed and comfortable with the change.
Addresses ongoing issues with epinephrine auto-injector shortages and brand monopolies. By making it easier to substitute different devices, the bill may help alleviate supply shortages and reduce dependence on a single brand, which can be an issue during manufacturing disruptions or price spikes.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Pharmacists
The bill would let them substitute a lower-cost epinephrine auto-injector with the same active ingredients, dosage form and strength even if it is not listed as interchangeable, subject to consent and counseling requirements.
Patients prescribed brand-name epinephrine auto-injectors
They could receive a lower-cost alternative with purchaser consent and instruction on its proper use and operating features.
Epinephrine prescribers
They could block substitution by indicating that the prescription must be dispensed as written.
Headline styles
Let Pharmacists Switch EpiPens
Plain English, a few words. Used as the page title.
Sponsors
Assembly Member · Assembly District 104
No co-sponsors yet.
History
- Referred to higher education
- Referred to higher education
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Allow Cheaper EpiPen Substitutes
In Assembly Committee · Higher Education · Sponsor Nathalia Fernandez
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
6988
2023-2024 Regular Sessions
IN ASSEMBLY
May 9, 2023
Introduced by M. of A. JACOBSON -- read once and referred to the Committee on Higher Education
AN ACT to amend the education law, in relation to the substitution of brand name epinephrine auto-injectors with alternate epinephrine autoinjectors for dispensation by pharmacists
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 6816-a of the education law is amended by adding a new subdivision 6 to read as follows:
6. (a) Notwithstanding subdivision two of this section or any other section of law to the contrary, when a patient is prescribed a brand name epinephrine auto-injector, a pharmacist may substitute an alternate epinephrine auto-injector containing the same active ingredients, dosage form and strength as the brand name product prescribed, ordered or demanded, regardless of whether the alternate epinephrine auto-injector is included in the latest list of interchangeable drug products for the prescribed epinephrine auto-injector device, provided that:
(i) the prescriber does not indicate that the prescription therefor shall be dispensed as written pursuant to paragraph (a) of subdivision six of section sixty-eight hundred ten of this article;
(ii) the alternate epinephrine auto-injector available would reflect a lower unit cost to the purchaser;
(iii) the pharmacist has advised the purchaser of the availability of an alternate epinephrine auto-injector and obtained consent to dispense the alternate epinephrine auto-injector; and
(iv) the pharmacist has counseled the patient or person authorized to act on the patient's behalf on the proper usage and operating features of the alternate epinephrine auto-injector.
(b) For purposes of this subdivision "epinephrine auto-injector" shall have the same meaning as provided in paragraph (b) of subdivision one of section three thousand-c of the public health law.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD08848-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.